Talecris Biotherapeutics

Talecris Biotherapeutics

Biotechnology, 79 Tw Alexander Dr, Research Triangle Park, North Carolina, 27709, United States, 1001-5000 Employees

talecris.com

  • facebook
  • LinkedIn

phone no Phone Number: +19*********

Who is TALECRIS BIOTHERAPEUTICS

We are a biopharmaceutical company that is one of the largest producers and marketers of plasma-derived protein therapies in the world. We develop, produce, market, and distribute therapi...

Read More

map
  • 79 Tw Alexander Dr, Research Triangle Park, North Carolina, 27709, United States Headquarters: 79 Tw Alexander Dr, Research Triangle Park, North Carolina, 27709, United States
  • 2005 Date Founded: 2005
  • 1001-5000 Employees: 1001-5000
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5122 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TALECRIS BIOTHERAPEUTICS

Talecris Biotherapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Talecris Biotherapeutics

Answer: Talecris Biotherapeutics's headquarters are located at 79 Tw Alexander Dr, Research Triangle Park, North Carolina, 27709, United States

Answer: Talecris Biotherapeutics's phone number is +19*********

Answer: Talecris Biotherapeutics's official website is https://talecris.com

Answer: Talecris Biotherapeutics's revenue is $100 Million to $250 Million

Answer: Talecris Biotherapeutics's SIC: 5122

Answer: Talecris Biotherapeutics's NAICS: 541714

Answer: Talecris Biotherapeutics has 1001-5000 employees

Answer: Talecris Biotherapeutics is in Biotechnology

Answer: Talecris Biotherapeutics contact info: Phone number: +19********* Website: https://talecris.com

Answer: We are a biopharmaceutical company that is one of the largest producers and marketers of plasma-derived protein therapies in the world. We develop, produce, market, and distribute therapies that extend and enhance the lives of people suffering from chronic and acute, often life-threatening, conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), primary immune deficiencies (PI), alpha-1 antitrypsin deficiency, bleeding disorders, infectious diseases and severe trauma. Our products are derived from human plasma, the liquid component of blood, which is sourced from our plasma collection centers or purchased from third parties, located in the United States.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access